Nigeria has secured a landmark deal to cut the cost of the twice-yearly HIV prevention injection, lenacapavir, from 28,000 dollars to just 40 dollars per person.
The Director-General of the National Agency for the Control of AIDS (NACA), Dr. Temitope Ilori, announced the breakthrough on the sidelines of the 80th United Nations General Assembly (UNGA) in New York.
Ilori described the deal as “a milestone” in the fight against HIV, noting that the injection—up to 100 per cent effective—will now be more accessible to millions at risk in Nigeria and beyond.
The agreement, achieved through collaboration with UNITAID, the Clinton Health Access Initiative, Wits RHI, Dr. Reddy’s Laboratories, and the Gates Foundation, is expected to accelerate efforts to end HIV as a public health threat by 2030.
NACA said the move underscores Nigeria’s commitment to expand access to prevention, strengthen health systems, and deepen global partnerships for a healthier, more resilient future.
